Results-One thousand and sixty two blood cultures were taken from patients in the ED during the study period. Ninety two (9%) returned a positive microbiological culture. Of these, 52 (5%) were "true" positives and 18 (1.6%) resulted in changes in management. Conclusions-Blood cultures taken in the ED rarely yield positive cultures. Only 1.6% of blood cultures taken in the ED impact on management of patients. Simple strategies could reduce the number of blood cultures ordered with little prospect of patient compromise. (MAccid Emerg Med 1998;15:254-256) 
Blood cultures are commonly part of the investigation of patients with suspected infective processes. Their use is recommended by major medical texts for the investigation of a wide variety of potential diagnoses. Despite this, there are no published studies that confirm their utility and/or clinical impact.
The indications for obtaining blood cultures from patients in the emergency department (ED) are even less clear. There is no clinical impact data specific to the ED practice setting and attempts to encourage informed use of this test are few.' It is the author's opinion that blood cultures are more often ordered "because the patient has a fever" or "the admitting registrar will want them" than for any expectation of clinical impact. In taken because the inpatient unit will require them. The underlying assumptions that the inpatient unit is always right and that the blood cultures will alter management have yet to be proved! In addition, there is a lack of appreciation of the sensitivity and specificity of blood cultures as a test. Studies have shown that in the presence of known major bacterial infection, blood cultures are only positive in up to 20% of cases.5 6 In most of these studies, multiple blood cultures have been taken, so the sensitivity of an individual test is likely to be lower than this. The pathology of the disease and thus the likelihood of bacteraemia must also be considered. An additional factor is the prevalent fallacy that if blood cultures are not performed initially, "the boat has been missed". Recent experience in oncology would challenge this belief. And it should be remembered that the rate of false positive blood cultures is approximately 50%,' a figure confirmed by the findings of this study.
The results of this study show that blood cultures obtained from patients in the ED rarely yield a result that impacts on patient management. This is consistent with the findings of previous studies.2 3 Assuming In the ED the decisions to be made are whether to admit the patient and which antibi- Table 3 Guidelines for ordering blood cultures in the ED Blood cultures should only be taken if: (1) After clinical assessment, the patient's illness is thought likely to be bacterial in origin and (2) No more direct specimen for culture (for example, urine, wound swab, cerebrospinal fluid, joint aspirate, etc) is practical and (3) The patient's condition is such that treatment as an inpatient is warranted Blood cultures should not be taken routinely from stable, immunocompetent patients with common or typical infections such as cellulitis, orchitis, and community acquired pneumonia otics (if any) to use. As the results of blood cultures are not available for several days, they have no impact on ED decision making. This rests on clinical assessment and more immediately available tests.
The ED diagnosis and disposal analysis suggests that the institution of some simple guidelines could markedly reduce the number of tests ordered and hence reduce investigation costs. For ease of use, this analysis has been simplified into the guidelines shown in table 3. It is estimated that the use of these guidelines would result in a 40% reduction in the number of blood cultures ordered that equates to a saving of approximately A$18 000 per annum for the study ED. This saving could be further increased if it was decided not to take blood cultures from selected patients with community acquired pneumonia.
It could be suggested that reducing the number of blood cultures taken would reduce the pool of microbiological data on which we base clinical decisions, particularly about the choice of antibiotic used as first line treatment. This is unlikely to apply because if appropriate direct specimens are taken (with their higher culture yield) the pool of microbiological data should be undiminished.
The finding that blood cultures taken in the ED have very low clinical impact should raise the same question about other tests used "routinely" in EDs such as abdominal radiography for abdominal pain and full blood examinations for a wide variety of illnesses. With significant budgetary constraints, we are challenged to understand the performance characteristics of the tests we use and their potential clinical impact in order to use them effectively and efficiently.
One of the biggest challenges to change in patterns of test ordering is changing attitudes outside the ED. This will require sharing of clinical impact data with inpatient clinicians and joint approaches to testing policy development.
Conclusion
Blood cultures taken in the ED rarely yield positive cultures. Only 1.6% of blood cultures taken in the ED impact on management of patients. Simple strategies could reduce the number of blood cultures ordered with little prospect of patient compromise.
